CTLA4 and hepatocellular carcinoma: In comparison with non-HBV HCC, levels of circulating Tregs were significantly increased in HBV-associated HCC [25,37,60] and expression levels of FOXP3 [25,37], CTLA-4, LAG-3, and PD-1 [37] increased in patients with HBV-associated HCC.